Ankle-brachial pressure index in people with type 1 diabetes
Keywords:
Type 1 Diabetes Mellitus; peripheral arterial disease; ankle-brachial pressure indexAbstract
Introduction: The natural history of diabetes mellitus includes the development of chronic lesions.
Objective: To describe the relationship among the index of pressures ankle-arm, factors aterogénicos and biochemical parameters in patient with diabetes type 1.
Methods: A descriptive-cross-sectional study was conducted. Methods at the theoretical level and statistical analysis of frequency and percentage were used for qualitative variables. Statistical test: Chi-square or Fisher's exact test to associate qualitative variables. Significance level: p < 0,05.
Results: The predominant groups were women between 30 and 39 years old (61,8 %), asymptomatic patients (97,2 %), hypertensive patients (32,6 %), smokers and ex-smokers (21,5 %), patients with more than 20 years of disease progression (54.2%), poor glycemic control (59,7 %) and glycosylated hemoglobin (41,0 %). According to the ankle-brachial index, 76,4 % were normal, 19,4 % were calcified, and only 4,2 % had peripheral arterial disease. There was no significant association between peripheral arterial disease and microvascular complications, but there was a significant association with coronary artery disease (p < 0.001).
Conclusions: A high index predominated; arterial hypertension and smoking were associated with peripheral arterial disease, and time of onset, and arterial hypertension with calcified arteries. There was no association between a low index and microvascular complications, but there was an association with coronary artery disease.
Downloads
References
1. Franco VD, López de Blanco C. Características clínicas de pacientes diabéticos manejados ambulatoriamente en el Instituto salvadoreño del Seguro Social. Alerta. 2022 [acceso 15/08/2025];5(1):33-42. Disponible en: https://camjol.info/index.php/alerta/article/view/10364
2. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2021. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2021 [acceso 15/08/2025]. Disponible en: http:///temas.sld.cu/estadisticassalud/
3. Autié Méndez L, Véliz Concepción OL, San Miguel Pentón A, García Sáez J, Águila Crespo LR. Particularidades de la erupción dentaria en individuos infanto-juveniles con enfermedades endocrinas frecuentes. Medicent Electron. 2019 [acceso 15/08/2025];23(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S102930432019000300192
4. Villena JE. Epidemiología de la diabetes mellitus en el Perú. Diagnóstico. 2019;55(4):173-81. DOI: https://10.33734/diagnostico.v55i4.21
5. Leal Ruiz E, Rodríguez Méndez L, Fusté Bruzain M. Complicaciones crónicas en pacientes con diagnóstico reciente de diabetes mellitus tipo 2. Medicentro Electrónica. 2019 [acceso 15/08/2025];23(2):136-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102930432019000200136&lng=es.
6. León-Rey CC, Lecuona-Huet NE, Mijangos WF, Betanco-Peña AX, Casares-Bran TM, Rodríguez-López JE. Propuesta de algoritmo diagnóstico en enfermedad arterial periférica con laboratorio vascular no invasivo en el Hospital General de México. Revista Mexicana de ANGIOLOGIA. 2017 [acceso 15/08/2025];45(4):170-92. Disponible en: https://www.medigraphic.com/pdfs/revmexang/an-2017/an174e.pdf
7. Diagnóstico y Tratamiento de la Enfermedad Arterial Periférica de Miembros Inferiores. Ciudad de México: Secretaría de Salud 2017 [acceso 15/08/2025]. Disponible en: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/007GER.pdf
8. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022. DOI: https://www.jacc.org/doi/10.1016/j.jacc.2021.12.011
9. Bervis Pérez EJ. Utilidad del índice Tobillo-Brazo en el diagnóstico de EAP en pacientes con DM hospitalizados en el Hospital Central Managua en el periodo 2016-2018 [acceso 15/08/2025]. Disponible en: https://www.semanticscholar.org/paper/Utilidad-del-indice-tobillo-Brazo-en-el-diagn%C3%B3stico-P%C3%A9rez-Jes%C3%BAs/041650f74eb9d4d1f1dcff971acc30c9aa15e9cf
10. World Medical Assocition Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):1-95. DOI: https://doi.org/10.1001/jama.2013.281053
11. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. 2022 [acceso 15/08/2025]. Disponible en: http://www.sld.cu/sitios/diabetes
12. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68 year old men with diabetes mellitus. European Journal of Vascular and Endovascular Surgery. 2005;29(2):182-9. DOI: https://doi.org/10.1016/j.ejvs.2004.10.019
13. Felício JS, Cavalcante C, Abdallah N, Resende FS, Nascimento de Lemos M, Corrêa RJM, et al. Ankle-brachial index and peripheral arterial disease: An evaluation including a type 2 diabetes mellitus drug-naïve patients cohort. Diab Vasc Dis Res. 2019;16(4):344-50. DOI: https://doi.org/10.1177/1479164119829385
14. Resnick HE, Lindsay RS, McDermott MM. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation. 2004;109(6):733-9. DOI: https://doi.org/10.1161/01.CIR.0000112642.63927.54
15. Ling Q, Zeng H, Liu F, Shen J, Li L, Zhao J, et al. Ankle-Brachial Index Indicates Cardiovascular and Peripheral Arterial Disease in Patients With Type 2 Diabetes. Angiology. 2015;66(10):918-24. DOI: https://doi.org/10.1177/0003319715573657
16. Nuez Vilar M, Castillo AB. Calidad de vida de diabéticos tipo 1 con tratamiento intensivo.Tesis. Ciudad de la Habana: Hospital Docente Clínico Quirúrgico Hermanos Ameijeiras. 2009 [acceso 15/08/2025]. Disponible en: http://www.hospitalameijeiras.sld.cu/hha/sites/all/informacion/mpm6/servicios-clinicos/endocrinologia/PROTOCOLO%20DIABETES%20MELLITUS%20TIPO%201ACTUAL%2021%20DE%20MARZO%202017.pdf
17. Nuez Vilar M, Lobaina Mosqueda Y. Caracterización de la Gastroparesia en diabéticos tipo 1 [tesis]. La Habana: Hospital Docente Clínico Quirúrgico Hermanos Ameijeiras. 2019 [acceso 15/08/2025]. Disponible en: http://www.hospitalameijeiras.sld.cu/hha/sites/all/informacion/biblioteca/Tesis%201.xls
18. Cicchitti A, Bertona C, González J, Carrasco N, Barrera L, David R, et al. Sobrepeso y obesidad en adultos con diabetes mellitus tipo 1. Rev Arg Diab. 2019 [acceso 15/08/2025];53:110-7. Disponible en: https://revistasad.com/index.php/diabetes/article/view/351
19. Kahkoska AR, Nguyen CT, Adair LA, Aiello AE, Burger KS, Buse JB, et al. Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications. J Clin Endocrinol Metab. 2019 [acceso 15/08/2025];104:6003-16. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31290977/
20. Van der Schueren B, Ellis D, Faradji RN, Al-Ozairi E, Rosen J, Mathieu C. Obesity in people living with type 1 diabetes. Lancet Diabetes Endocrinol. 2021 [acceso 15/08/2025];9(11):776-85. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34600607/
21. Edqvist J, Rawshani A, Adiels M. BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox. Diabetes Care. 2019 [acceso 15/08/2025];42:1297-304. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31048408/
22. Melo Polo M. Portilla Maya A. Control Glucémico en pacientes con Diabetes Mellitus de una consulta especializada. Rev Colom Endocrinol Diabet Metab. 2021;8(1):e664. DOI: https://doi.org/10.50383/encr.8.1.664
23. Wilcox T, Newman JD, Maldonado TS, Rockman C, Berger JS. Peripheral vascular disease risk in diabetic individuals without coronary heart disease. Atherosclerosis. 2018;(18)30211-9. DOI: https://doi.org/10.1016/j.atherosclerosis.2018.04.026
24. Liu H, Liu J, Zhao H, Wang H; BEST Research Group. Relationship between glycated hemoglobin and low Ankle-Brachial Index: a cross-sectional observational study from the Beijing Vascular Disease Evaluation Study (BEST Study). Int Angiol. 2019;38(6):502-7. DOI: https://doi.org/10.23736/S0392-9590.19.04210-X
25. Guía ESC/EAS 2019 sobre el tratamiento de las dislipdiemias: modificación de los lípidos para reducir el riesgo cardiovascular. Rev Esp Cardiol. 2020;73(5):403-70. DOI: https://doi.org/10.1016/j.recesp.2019.10.031
26. Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol. 2016 [acceso 15/08/2025];15:129-32. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010714/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marisela Nuez Vilar, Leonardo Gutiérrez Alemán, Sergio Enrique Zayas Puig, Noraika Domínguez Pacheco, Idania María Reyes Martínez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
